SBIO vs SCHD

ASBIO

BSCHD

Measures won1–5SCHD wins · of 6 · 5Y

$10,000 · 5Y$16,418SCHD · SBIO $12,211

Lowest cost0.06%SCHD · $6 on $10k

Most income2.93%SCHD · $293 on $10k

Smallest drop−6.9%SCHD · worst fall in 1Y

Held in common0.0%SBIO and SCHD

ALPS Medical Breakthroughs ETF · $193MSchwab U.S. Dividend Equity ETF · $123B

+33.2%3 years · per year$23,657 · $17,234+19.9%

+4.1%5 years · per year$12,211 · $16,418+10.4%

0.50%Expense ratio$50 · $6 on $10k · lower wins0.06%

0.00%12-mo yield$0 · $293 on $10k2.93%

−29.2%

End-of-day Nov 11, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk		0.06%	2.93%	+0.5%	+34.6%	+39.3%	+19.9%	+10.4%	−6.9%	$122.7B
2	ASBIO	ALPS Medical Breakthroughs ETFRead Desk		0.50%	0.00%	+1.1%	+13.7%	+31.0%	+33.2%	+4.1%	−29.2%	$193M

End-of-day Nov 11, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk		0.06%	2.93%	+0.5%	+34.6%	+39.3%	+19.9%	+10.4%	−6.9%	$122.7B
2	ASBIO	ALPS Medical Breakthroughs ETFRead Desk		0.50%	0.00%	+1.1%	+13.7%	+31.0%	+33.2%	+4.1%	−29.2%	$193M

End-of-day Nov 11, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

SBIO

ALPS Medical Breakthroughs

$12,211

SCHD

Schwab U.S. Dividend Equity

$16,418

Loading…